Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Basic) (2020 - 2025)

Biofrontera (BFRI) has 6 years of EPS (Basic) data on record, last reported at -$0.63 in Q3 2025.

  • For Q3 2025, EPS (Basic) fell 36.96% year-over-year to -$0.63; the TTM value through Sep 2025 reached -$1.5, down 229.31%, while the annual FY2024 figure was -$3.22, 75.27% up from the prior year.
  • EPS (Basic) reached -$0.63 in Q3 2025 per BFRI's latest filing, down from -$0.57 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.55 in Q4 2023 and bottomed at -$12.45 in Q2 2023.
  • Average EPS (Basic) over 5 years is -$1.23, with a median of -$0.47 recorded in 2025.
  • The widest YoY moves for EPS (Basic): up 262.5% in 2023, down 1283.33% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$1.38 in 2021, then crashed by 102.9% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then crashed by 96.26% to $0.17 in 2024, then crashed by 470.59% to -$0.63 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.63 in Q3 2025, -$0.57 in Q2 2025, and -$0.47 in Q1 2025.